Endocarditis and bacteraemia due to Gram-positive species

• 1123 • Is the modified quick (sequential organ failure assessment) SOFA scale superior to quick SOFA in patients with diagnosed septic shock? > D. Deniz AKYOL (Izmir) • 122 • Retrospective analysis of 291 cases of <em>Staphylococcus aureus</em> bacteraemia (SAB) at the University Hospital of Leipzig, Germany: assessment of adherence to the SAB care bundle, molecular characterisation of strains, and their effect upon clinical outcomes > S. Sandra GRAEBER (Leipzig) • 1221 • Role of thoracoabdominal or cerebral imaging studies in patients with suspected infective endocarditis > M. Matthaios PAPADIMITRIOU-OLIVGERIS (Lausanne) • 1615 • Penicillin plus gentamicin versus ampicilin/sulbactam plus gentamicin in the empirical therapy of native valve infective endocarditis > D. Deniz AKYOL (Izmir) • 1627 • Daptomycin versus vancomycin for the treatment of methicillin-resistant <em>Staphylococcus aureus</em> bloodstream infection and endocarditis: a systematic review and meta-analysis > A. Alberto Enrico MARAOLO (Marcianise (Ce)) • 2241 • Treatment duration for central line-associated infection caused by <em>Enterococcus </em>spp: a retrospective evaluation of a multi-centre cohort > M. Michele BARTOLETTI (Bologna) • 2655 • Presentation and management of relapsed <em>Enterococcus faecalis</em> endocarditis > P. Pierre DANNEELS (Angers) • 266 • Investigation of <em>Actinomyces</em> spp. bacteraemia in Glasgow, Scotland and associated 1 year mortality > G. Guy MOLLETT (Glasgow) • 2797 • Cardiac magnetic resonance imaging for the diagnosis of infective endocarditis in the COVID-19 era > S. Sapan BHUTA (Toledo, Oh) • 3067 • Risk factors for persistent enterococcal bacteraemia: a multi-centre retrospective study > L. Linda BUSSINI (Bologna) • 3239 • Impact of penicillin intermediate resistance on the outcomes of infective endocarditis caused by viridans and gallolyticus group streptococci > F. Francesc ESCRIHUELA-VIDAL (Barcelona) • 3593 • Effectiveness of a unique blood culture strategy in the intensive care unit: a before and after study > R. Rafael MAHIEU (Angers) • 3870 • Comparable efficacy of antibiotic monotherapy and antibiotic combination therapies for enterococcal endocarditis: a retrospective study at a large tertiary care centre in Vienna > L. Lorenz SCHUBERT (Vienna) • 4223 • Diagnostic accuracy of risk scores for <em>Staphylococcus aureus</em> endocarditis > T. Thomas Wouter VAN DER VAART (Amsterdam) • 4312 • Prevalence of positive follow-up blood cultures in non-staphylococcal endocarditis > T. Thomas Wouter VAN DER VAART (Amsterdam) • 562 • Does prevention of thrombotic events by anticoagulants or antiaggregants also help prevent infective endocarditis? > H. Hanne THEYS (Denderhoutem) • 881 • Natural history of valve vegetations in early stages of experimental endocarditis caused by most common Gram-positive cocci > A. Anders DAHL (Hellerup) • 90 • Dalbavancin compared to standard of care for outpatient treatment of confirmed or suspected invasive methicillin-resistant <em>Staphylococcus aureus</em> infections in people who inject drugs > M. Michael VEVE (Detroit) • 91 • Predictors of treatment failure in persistent methicillin-resistant <em>Staphylococcus aureus</em> bloodstream infections: a focus on combination therapy > M. Michael VEVE (Detroit)